Although some details are still murky, a first-blush analysis of Obama Administration’s fiscal year 2011 budget doesn’t look good for US efforts to combat the HIV and tuberculosis epidemics. From treatment to prevention, these global health threats could get short-changed under the White House plan. Let’s start with PEPFAR, the President’s Emergency Plan for AIDS Relief. […]
New results from a tuberculosis vaccine trial indicate that the Mycobacterium vaccae (MV) was effective in preventing TB among people with HIV. Given that TB is the No. 1 killer of people with HIV in the developing world, this could be a major advance in the battle against these synergistic scourges. In the seven-year study […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]